Israeli-Dutch clinical stage biotech company Prilenia Therapeutics has announced a collaboration and licensing agreement for its lead drug Pridopidine,…
Tag: Teva
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…
Analysts remain positive on Teva
The quarterly and annual financials of Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) released last Wednesday sent the company’s…
Teva CEO responds to 25% share price fall
Since publishing its financial results for 2024 at the end of January, the share price of Teva Pharmaceutical Industries…
Teva files to raise first capital since 2016
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has filed a shelf prospectus with the US Securities and Exchange…